Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Condition(s) studied
Investigational drug(s) / intervention(s)
Thermodilution based assessment of coronary microcirculation: Coronary microvascular assessment with the derivation of CFR, IMR and MRR will be performed using a standard pressure/thermodilution guidewire.
Study summary
Patients presenting with idiopathic dilated cardiomyopathy and left ventricle dysfunction (LVEF \<40%), naive of anti-remodeling cardiac medical therapy, will undergo invasive coronary microvascular assessment based on thermodilution. The primary endpoint, namely the left ventricle reverse remodeling, will be assessed after 12 months of optimal medical therapy based on transthoracic echocardiography. The primary endpoint will be evaluated by an independent central core lab. Patients enrolled in the study will be followed for a period of 5 years to monitor their clinical status. During the study period participants may undergo multimodality diagnostic tests including ECG telemetry monitoring, cardiopulmonary exercise testing, cardiovascular cardiac magnetic resonance.
Eligibility
Primary outcome measure(s)
- Rate of Left ventricular reverse remodeling (LVRR) — After 12 months of guidelines directed optimal medical therapy
LVRR, defined as LVEF increase ≥ 10% and LVEDDi decrease ≥ 10%, will be assessed with transthoracic echocardiography and analyzed off-line by an independent central corelab.
Trial sites (12)
| Facility | City | Region | Status |
|---|---|---|---|
| Azienda Ospedaliera Universitaria di Ferrara | Ferrara | Ferrara | |
| UOC Cardiologia, PO di Conegliano | Conegliano | Italy | |
| Azienda Ospedaliero-Universitaria Maggiore della Carità | Novara | Italy | |
| Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) dell'Ospedale San Raffaele | Milan | Milan | |
| Ospedale Galeazzi di Sant'Ambrogio IRCCS | Milan | Milan | |
| Fondazione Policlinico Universitario A. Gemelli IRCCS | Roma | Roma | |
| Azienda Ospedaliero-Universitaria Sant'Andrea | Rome | Rome | |
| Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino | Torino | Torino | |
| Azienda Ospedaliera Universitaria di Verona | Verona | Verona | |
| Università della Calabria | Cosenza | Italy | |
| University of Naples Federico II | Naples | Italy | |
| Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano | Orbassano | Italy |
More Azienda Ospedaliera Universitaria Integrata Verona trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06356727 on ClinicalTrials.gov ↗ ← All trials in Italy